Candel Therapeutics Inc. (CADL) PT Raised to $25 at Canaccord Genuity
Tweet
Share
E-mailGet Alerts CADL Hot Sheet
Price: $11.80 --0%
Rating Summary:
12 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 7 | New: 5
Rating Summary:
12 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 7 | New: 5
Join SI Premium – FREE
Canaccord Genuity analyst John Newman raised the price target on Candel Therapeutics Inc. (NASDAQ: CADL) to $25.00 (from $20.00) while maintaining a Buy rating.
You May Also Be Interested In
- Candel Therapeutics Inc. (CADL) PT Raised to $12 at BofA Securities
- Yeti Holdings Inc. (YETI) PT Raised to $48 at BofA Securities
- Tapestry Inc. (TPR) PT Raised to $232 at UBS
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
